MoonLake Immunotherapeutics, (MLTX): Price and Financial Metrics
MLTX Price/Volume Stats
| Current price | $43.81 | 52-week high | $64.98 |
| Prev. close | $41.47 | 52-week low | $37.55 |
| Day low | $41.92 | Volume | 808,000 |
| Day high | $44.90 | Avg. volume | 522,564 |
| 50-day MA | $51.48 | Dividend yield | N/A |
| 200-day MA | $46.82 | Market Cap | 2.80B |
MLTX Stock Price Chart Interactive Chart >
MoonLake Immunotherapeutics, (MLTX) Company Bio
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
MLTX Price Returns
| 1-mo | -16.02% |
| 3-mo | -5.97% |
| 6-mo | -2.45% |
| 1-year | -20.92% |
| 3-year | 342.75% |
| 5-year | N/A |
| YTD | -19.10% |
| 2024 | -10.33% |
| 2023 | 475.14% |
| 2022 | 6.17% |
| 2021 | -13.02% |
| 2020 | N/A |
Loading social stream, please wait...